Company

PinkDx, Inc.

PinkDx develops diagnostic tests using patient samples, bioinformatics, and machine learning.

About

PinkDx combines patient samples, genetic information, medical history, and clinical data to develop diagnostic tests. Founded in 2022 by Bonnie Anderson (CEO), Tim McMeekan, and Giulia Kennedy, the company is based in California, US. It raised USD 40 million in Series A funding in April 2024, then USD 5 million in January 2025 from returning investors The Production Board, Mountain Group Partners, Catalio Capital Management, Byers Capital, and Mayo Clinic Ventures, along with BlueTree Venture Fund, Sandbox Industries, BEVC, and individual investors. The January round formed part of a larger USD 45 million Series A and was intended to advance its test for women with possible gynecologic cancer.

2Funding rounds

8Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in